Abstract
Background
Herbal medicines have been used in the treatment of liver diseases for a long time. In recent years, the use of herbal medicines for protection from other strong antibiotics as well as drugs that can damage the liver during their metabolism in liver and for treatment of liver diseases has increased all over the world. It is important to mention that a number of organic solvents are used at different stages of extraction/formulation development for these traditional preparations in industries/pharmacies. In addition, some of these solvents possess established carcinogenic properties and may enter the formulation as residual solvents. Hence as per ICH guidelines it is mandatory to keep the level of these solvents up to permissible limits. There has been a lot of hue and cry that ayurvedic formulations available in the market are not properly standardized for their quality due to lack of stringent regulations and standards from regulatory authorities. Therefore the aim of present work was to assess the compliance of ICH guidelines for level of organic volatile impurities in common marketed ayurvedic hepatic formulations.
Methods
In this study, 25 ayurvedic herbal formulations available as OTC product have been assessed for presence of residual solvents using gas chromatography with flame ionization detector.
Results
This study on 25 fast moving hepatic formulations in the market reflects that no residual solvents were detected in any of the formulations however if present were within prescribed permissible limits of ICH guidelines. The data was also subjected to statistical analysis (F-test and t-test at 95% confidence level).
Conclusions
Results indicate the safety of these hepatic formulations with respect to residual solvents. In addition presents a simple, linear, specific, accurate, precise and rugged gas chromatographic method for estimation of residual solvents.
Acknowledgments:
The authors are highly thankful to authorities of Baba Farid University of Health Sciences, Faridkot for necessary permission and providing all research facilities.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
Conflict of interest: None declared.
References
[1] Ming H, Sha L, Hor YT, Ning W, Sai WT, Yibin F. Current status of herbal medicines in chronic liver disease therapy: the biological effects, molecular targets and future Prospects. Int J Mol Sci 2015;16:28705–45.10.3390/ijms161226126Search in Google Scholar PubMed PubMed Central
[2] Dhiman A, Nanda A, Ahmad S. A recent update in research on the antihepatotoxic potential of medicinal plants. J Chin Integr Med 2012;10:117–27.10.3736/jcim20120201Search in Google Scholar PubMed
[3] Del PA, Scalera A, Iadevaia MD, Miranda A, Zulli C, Gaeta L, et al. Herbal products: benefits, limits, and applications in chronic liver disease. Evid Based Complement Altern Med 2012;2012:837939.Search in Google Scholar
[4] Uorakkottil I, Deepshikha PK, Vidhu A, Punnooth PN. A review on hepatoprotective and immunomodulatory herbal plants. Pharmacogn Rev 2016;10:66–70.10.4103/0973-7847.176544Search in Google Scholar PubMed PubMed Central
[5] Girish C, Bidhan CK, Jayanthib S, Ramachandra KR, Rajesh B, Suresh CP. Hepatoprotective activity of six polyherbal formulations in CCl4-induced liver toxicity in mice. Indian J Exp Biol 2009;47:257–63.Search in Google Scholar PubMed
[6] El-Shenawy SM, Hassan NS. Comparative evaluation of the protective effect of selenium and garlic against liver and kidney damage induced by mercury chloride in the rats. Pharmacol Rep 2008;60:199–208.Search in Google Scholar PubMed
[7] Subramoniam A, Pushpangadan P. Development of phytomedicines for liver diseases. Indian J Pharmacol 1999;31:166–75.Search in Google Scholar
[8] Vong S, Bell BP. Chronic liver disease mortality in the United States, 1990–1998. Hepatology 2004;39:476–83.10.1002/hep.20049Search in Google Scholar PubMed
[9] Kupeli E, Orhan DD, Yesilada E. Effect of Cistus laurifolius L. leaf extracts and flavonoids on acetaminophen-induced hepatotoxicity in mice. J Ethnopharmacol. 2006;103:455–60.10.1016/j.jep.2005.08.038Search in Google Scholar PubMed
[10] Evans WC. An overview of drugs having antihepatotoxic and oral hypoglycaemic activities. In: Trease and Evans’ WC, eds. Phamacognosy, 14th ed. UK: W.D. Sanders Company Ltd, 1996.Search in Google Scholar
[11] Gupta V, Bansal P, Bansal R, Kumar S. Value addition by standardization of herbal drugs at global level – a review. Arch Pharm Sci Res 2010;2:326–30.Search in Google Scholar
[12] Zhang A, Sun H, Wang X. Recent advances in natural products from plants for treatment of liver diseases. Eur J Med Chem 2013;63:570–7.10.1016/j.ejmech.2012.12.062Search in Google Scholar PubMed
[13] Anupama RV, Neelam M, Rajani BA, Narendra SB. Hepatoprotective ayurvedic plants – a review. J Complement Integr Med 2016;13:207–15.10.1515/jcim-2015-0110Search in Google Scholar PubMed
[14] Ayurvedic Formulary of India, Part I & II. Department of AYUSH, Ministry of Health & Family Welfare, New Delhi, Government of India; 2005.Search in Google Scholar
[15] Gupta V, Bansal P, Kumar S, Bansal R, Meena AK, Sharma S. Chromatographic techniques in standardization of herbal drugs – a review. J Punjab Acad Sci 2010;5–6:24–30.Search in Google Scholar
[16] Meena AK, Bansal P, Kumar S. Herbal wealth as a potential source of ayurvedic drugs. Asian J Tradit Med 2009;4:152–70.Search in Google Scholar
[17] Ghosh A, Kundu A, Seth A, Singh AK, Maurya SK. Preliminary evaluation of hepatoprotective potential of the polyherbal formulation. J Intercult Ethnopharmacol 2015;4:118–24.10.5455/jice.20141121060725Search in Google Scholar PubMed PubMed Central
[18] Dhiman RK, Chawla YK. Herbal medicines for liver diseases. Dig Dis Sci 2005;50:1807–12.10.1007/s10620-005-2942-9Search in Google Scholar PubMed
[19] Seth SD, Sharma B. Medicinal plants of India. Ind J Med Res 2004;120:9–11.Search in Google Scholar
[20] Chattopadhyay R. Possible mechanism of hepatoprotective activity of Azadirachta indica leaf extract: part II. J Ethnopharmacol. 2003;89:217–9 .10.1016/j.jep.2003.08.006Search in Google Scholar PubMed
[21] Handa SS, Sharma A, Chakraborty KK. Natural products and plants as liver protecting drugs. Fitoterapia 1989;57:307–51.Search in Google Scholar
[22] Hikino H, Kiso Y. Natural products for liver diseases. In: H. Wagner, Hiroshi Hikino, Norman Farnsworth, eds. Economic and medicinal plant research, vol. 2. London: Academic Press, 1988:39-72.Search in Google Scholar
[23] Doreswamy R, Sharma D. Plant drugs for liver disorders management. Indian Drugs. 1995;32:139–44.Search in Google Scholar
[24] Rajesh MG, Latha MS Preliminary evaluation of the antihepatotoxic activity of Kamilari, a polyherbal formulation. J Ethnopharmacol 2004;91:99.10.1016/j.jep.2003.12.011Search in Google Scholar PubMed
[25] Jaeschke H. Reactive oxygen and mechanisms of inflammatory liver injury: present concepts. J Gastroenterol Hepatol 2011;26:173–9.10.1111/j.1440-1746.2010.06592.xSearch in Google Scholar PubMed
[26] Wang T, Sun NL, Zhang WD, Li HL, Lu GC, Yuan BJ, et al. Protective effects of dehydrocavidine on carbon tetrachloride-induced acute hepatotoxicity in rats. J Ethnopharmacol 2008;117:300–8.10.1016/j.jep.2008.02.010Search in Google Scholar PubMed
[27] ICH guidelines, Analytical method validation (Q3). Geneva, 2000.Search in Google Scholar
[28] ICH. Validation of analytical procedures and methodology, in Proceedings of the International Conference on Harmonization, Geneva, Switzerland, 2005.Search in Google Scholar
[29] Pharmacopoeia U.S. USP-NF <1225> Validation of Compendial Methods. USP 32-NF27. 2009.Search in Google Scholar
[30] FDA guidance for industry, Analytical procedure and method validation for drugs and biologics, Food and Drug administrator, 2015.Search in Google Scholar
[31] Rustichelli D, Castiglia S, Gunetti M. Validation of analytical methods in compliance with good manufacturing practice: a practical approach. J Trans Med 2013;11:197–210.10.1186/1479-5876-11-197Search in Google Scholar PubMed PubMed Central
[32] Pasbola K, Chaudhary M. Updated review on analytical method development and validation by HPLC. World J Pharm Pharm Sci 2017;6:1612–30.10.20959/wjpps20175-9228Search in Google Scholar
[33] Belouafa S, Habti F, Benhar S, Belafkih B, Tayane S, Hamdouch S, et al. Statistical tools and approaches to validate analytical methods: methodology and practical examples. Int J Metrol Qual Eng 2017;8:1–10.10.1051/ijmqe/2016030Search in Google Scholar
© 2019 Walter de Gruyter GmbH, Berlin/Boston
